Vocus Group Ltd (VOC) – NEUTRAL
VVR reported solid 1H18 results with distributable earnings of 6.99cps, a +2.8% uplift. In line with the 100%
Analyst Research
Analyst Research
Virtus Health Ltd (VRT) – Buy
Virtus Health Ltd (VRT) reported FY18 results missed analyst expectations, with net income of $30.7m -2.8% below consensus
Analyst Research
Nine Entertainment (NEC) – BUY
NEC reported a very strong result for FY18, with revenue up +6%, group EBITDA up +25% and EPS
Analyst Research
Viva Energy REIT Ltd (VVR) – BUY
VVR reported solid 1H18 results with distributable earnings of 6.99cps, a +2.8% uplift. In line with the 100%
Analyst Research
Arena REIT (ARF) – Buy
Arena REIT (ARF) reported solid FY18 results largely in line with market expectations with solid headline numbers with
Analyst Research
Medibank Private (MPL) – BUY
Medibank Private (MPL) reported FY18 results with NPAT of 445.1m and EPS of 16.2cps, both of which came
Analyst Research
Coca-Cola Amatil (CCL) – Neutral
CCL’s 1H18 result highlighted improving conditions in the core Australian Beverage segment, ongoing strength in the NZ /
Analyst Research
South32 Ltd (S32) – BUY
South32 (S32) FY18 result was solid in our view, with underlying EPS up +19% to US10.5cps, and revenue
Analyst Research
Brambles Ltd (BXB) – BUY
Brambles (BXB) FY18 result represents a resilient performance in times of significant costs inflation.
Analyst Research
WiseTech Global (WTC) – Sell
WTC reported a very strong FY18 result, which came in ahead of consensus and company guidance. Compared to